Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
University Hospital, Limoges |
---|---|
Information provided by: | University Hospital, Limoges |
ClinicalTrials.gov Identifier: | NCT00954616 |
In each of the 7 French areas that should be involved, patients aged 75 years and over from three different sectors will be included: the geriatric consultation unit (60%) and two kinds of nursing homes, private (20%) and state (10%). Outpatients will be included in chronological order; patients in nursing homes will be included at random. The patients and their families will be asked about the treatments received on the day of inclusion. The inclusion period will extend over a year. The investigating practitioners will be asked to fill in a questionnaire reporting the main clinical data, adverse effects occurrence, and information on the treatment given.
Condition |
---|
Alzheimer's Disease |
Study Type: | Observational |
Study Design: | Case-Only, Prospective |
Official Title: | Inappropriate Medications and Alzheimer Disease: Prevalence and Associated Factors in Elderly Patients Treated With Anticholinesterase and/or Memantine. MIDA Study. |
Estimated Enrollment: | 700 |
Study Start Date: | January 2009 |
Estimated Study Completion Date: | January 2011 |
Primary Completion Date: | February 2009 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 75 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Patient of 75 and more years old affected by the Alzheimer's disease
Inclusion Criteria:
Exclusion Criteria:
Contact: Marie - Laure LAROCHE, Doctor | 0555056743 | marie-laure.laroche@chu-limoges.fr |
France | |
CHU Saint Etienne | Recruiting |
Saint Etienne, France, 42 055 | |
Contact: Catherine TERRAT, Doctor | |
Principal Investigator: Catherine TERRAT, Doctor | |
France, Bois guillaume | |
CHU Rouen | Recruiting |
Rouen, Bois guillaume, France, 76 230 | |
Contact: Jean DOUCET, Porfessor 02 32 88 90 42 | |
Principal Investigator: Jean DOUCET, Professor | |
France, Bordeaux | |
CHU Bordeaux | Recruiting |
Pessac, Bordeaux, France, 33 604 | |
Contact: Muriel RAINFRAY, Professor | |
Principal Investigator: Muriel RAINFRAY, Professor | |
France, Le Mans Cedex 1 | |
CH Le Mans | Recruiting |
Le Mans, Le Mans Cedex 1, France, 72 037 | |
Contact: Emmanuel ALIX, Doctor | |
Principal Investigator: Emmanuel ALIX, Doctor | |
France, Montpellier Cedex 5 | |
CHU Montpellier | Recruiting |
Montpellier, Montpellier Cedex 5, France, 34 295 | |
Contact: Claude JEANDEL, Professor 04 67 33 96 01 | |
Principal Investigator: Claude JEANDEL, Professor | |
France, Paris | |
APHP Charles Foix | Recruiting |
Ivry sur Seine, Paris, France, 94 205 | |
Contact: Aurora LALHOU, Doctor | |
Principal Investigator: Aurora LALHOU, Doctor |
Responsible Party: | CHU Limoges ( Marie Sengelen / Directrice de la Recherche clinique et de l'Innovation ) |
Study ID Numbers: | I07033 |
Study First Received: | July 31, 2009 |
Last Updated: | August 5, 2009 |
ClinicalTrials.gov Identifier: | NCT00954616 History of Changes |
Health Authority: | France: Afssaps - French Health Products Safety Agency |
Inappropriate Medications Associated Alzheimer's disease |
Neurotransmitter Agents Alzheimer Disease Central Nervous System Diseases Brain Diseases Neurodegenerative Diseases Cholinergic Agents Cognition Disorders |
Cholinesterase Inhibitors Delirium, Dementia, Amnestic, Cognitive Disorders Mental Disorders Memantine Dementia Delirium |
Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Physiological Effects of Drugs Alzheimer Disease Nervous System Diseases Central Nervous System Diseases Enzyme Inhibitors Cholinergic Agents |
Brain Diseases Neurodegenerative Diseases Pharmacologic Actions Cholinesterase Inhibitors Delirium, Dementia, Amnestic, Cognitive Disorders Mental Disorders Dementia Tauopathies |